pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccination 96

Vaccination Vaccine Production Licensing 96

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

World of DTC Marketing

MARCH 11, 2022

3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

Drug Discovery World

DECEMBER 6, 2023

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%

Life Science 59

Life Science Branding Medicine Pharma Companies 59

World of DTC Marketing

APRIL 14, 2021

QUICK READ: Pfizer has already announced a price increase to the EU for their Covid Vaccine. The company announced last month that it expects to make $15bn (£10.9bn) off its coronavirus vaccine this year based on current deals. billion to develop one new medicine, including the cost of the many failures.”

Pharma Companies 191

Pharma Companies Vaccination Vaccine Sales 191

The Pharma Data

DECEMBER 4, 2020

After an incredible milestone for science, this week we bring our readers news from Pfizer and BioNTech on the promise of a Covid-19 vaccine result. Pfizer and BioNTech achieve first authorization use for their Covid-19 vaccine in the UK. Our aim is to bring a safe and effective vaccine upon approval to the people who need it.

Vaccination 52

Vaccination Vaccine Pharma Companies Medicine 52

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). costs about $700. spending annually.

Regulation 218

Regulation Drugs Bioequivalency Pharmacy 218

World of DTC Marketing

APRIL 7, 2021

Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Already vaccine makers are saying that we may need a Covid Vaccine booster shot every year even though there is no long term data as of yet. Walgreens Boots Alliance, Stefano Pessina — $19.2

Vaccination 162

Vaccination Vaccine Doctors Doctor 162

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

World of DTC Marketing

AUGUST 10, 2021

SUMMARY : Falsehoods have been shown to spread faster and farther than accurate information, and research suggests that misinformation can have negative effects in the real world, such as amplifying controversy about vaccines and propagating unproven cancer treatments.

Production 180

Production Pharma Companies Doctors Doctor 180

pharmaphorum

DECEMBER 21, 2020

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks Richard Staines. A year ago, the names Moderna and BioNTech were known mainly to those who followed biotech and pharma dealings.

Vaccination 111

Vaccination Vaccine Doctors Doctor 111

World of DTC Marketing

MAY 19, 2021

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. A “critical part” of pharmaceutical company AbbVie ‘s success is “face-to-face” interaction, CEO Richard Gonzalez explained in an Aug. 27 email outlining its process for bringing thousands of U.S.

Pharma Companies 181

Pharma Companies Drugs Branding Manufacturing 181

Delveinsight

DECEMBER 15, 2020

The FTA designation will help the pharma company to advance its research and development in the NASH landscape and help its commercialization in the market. The present NASH treatment market is dominated and supported by off-label therapies. Pfizer, BioNTech COVID-19 Vaccine rolls out in a watershed moment.

Vaccination 54

Vaccination Vaccine Gene Therapy Gene 54

XTalks

MAY 29, 2024

The Financial Times’ list of the Americas’ Fastest Growing Companies 2024 provides an insight into the market’s leaders in terms of growth, highlighting not the size of companies but their capacity for innovation. The list features companies from all spheres such as IT, Marketing, Finance and more.

Medicine 52

Medicine Marketing FDA Approval Development 52

World of DTC Marketing

DECEMBER 18, 2020

Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.

Generic Drugs 155

Generic Drugs Drugs Pharma Companies Vaccination 155

pharmaphorum

FEBRUARY 18, 2021

The South African coronavirus variant may cut the effectiveness of Pfizer/BioNTech’s vaccine by around two thirds, according to a laboratory study. Results published in the New England Journal of Medicine found that the virus with all the mutations seen in the South African strain – known as B.1.351

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

JUNE 11, 2021

Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of its vaccine candidate. The Russian Sputnik V vaccine was approved for use in India in April. 1.351) variant. million doses.”

Vaccination 83

Vaccination Vaccine Licensing Licensing 83

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195

pharmaphorum

NOVEMBER 16, 2020

EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and becoming the first women in the role. Cooke is returning to the EMA after a four-year period as head of medicines regulation at the World Health Organization (WHO). Emer Cooke.

Regulation 64

Regulation Medicine Vaccination Vaccine 64

pharmaphorum

DECEMBER 29, 2022

At the same time, the industry must address the long-term difficulty of providing essential medicines and health services to the high percentage of global population that cannot access them because of costs. Ensuring on-time delivery of life-saving medicine. Crisis readiness and digital workflows.

Manufacturing 111

Manufacturing Medicine Pharma Companies Engineer 111

XTalks

MAY 23, 2024

The pharmaceutical and biotech sectors are prominently featured, with various companies demonstrating their effectiveness in fostering a content and productive workforce. Let’s take a closer look at the pharmaceutical and biotech companies on this list. Rank 208) Established in 1891, Merck & Co.,

Life Science 52

Life Science Medicine Manufacturing Engineer 52

XTalks

DECEMBER 20, 2023

And this year Eli Lilly stepped into the obesity drug market with its own GLP-1 weight loss drug Zepbound (tirzepatide), which the US Food and Drug Administration (FDA) approved in November of this year. Check out this article to learn about the biotech companies that went public this year.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

SEPTEMBER 9, 2022

Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. “Any Vulnerability . Making plans is not enough.

Production 105

Production Pharma Companies Generic Drugs Contamination 105

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. — Tinglong Dai (@TinglongDai) January 5, 2021.

DNA 116

DNA Branding Vaccination Vaccine 116

Drug Discovery World

OCTOBER 6, 2022

This growth is due to factors including a rise in speciality medicines, an increase in lifestyle-driven diseases and a growing population 1. Accounting for 20% of the total global pharma market, Europe is a key market for biotech business, particularly those looking to bring new products to market 3. Valued at $14.8

Development 52

Development Drugs Life Science Marketing 52

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 98

Life Science Marketing Medicine Production 98

Drug Discovery World

MARCH 29, 2023

An example of the current disparity, drawn from data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), can be seen in Romania, Poland or Bulgaria, where a recently approved medicine will take more than 800 days on average before it becomes publicly available compared with Germany, where that figure is 133 days 3.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms.

Vaccination 98

Vaccination Vaccine Sales Drugs 98

pharmaphorum

DECEMBER 2, 2020

After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr Pepper’s expansion in the 1880s. By 1868, Pfizer’s revenues had doubled since the start of the war, and their product lines had expanded greatly.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

DECEMBER 16, 2020

We’ve also seen a very mixed picture in the market for pharmaceuticals,” he says. We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. The road to a vaccine. A collaborative future. If we lose them it will be a massive problem.

Vaccination 122

Vaccination Vaccine Life Science In-Vitro 122

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

FEBRUARY 14, 2022

The easy answer as to why this has happened can be quickly linked to the COVID-19 pandemic, where sales of vaccines and treatments led to a large increase in return on investment and sales projections. This can be understood through the accelerated development cycles experienced on COVID-19 treatments and vaccines.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

APRIL 22, 2021

Centessa is led by CEO Saurabh Saha, formerly head of translational medicine at Bristol-Myers Squibb and is the brainchild of chairman, the biotech investor Francesco de Rubertis. The company has an “asset focused” R&D philosophy , where development is centred on the needs of each individual biotech.

Licensing 64

Licensing Licensing Pharma Companies Drugs 64

XTalks

MAY 25, 2021

AbbVie (NYSE:ABBV) continues to face heat over complaints of patent exploitation and price hikes of its world’s best-selling drug Humira (adalimumab) to build a market monopoly and block out Humira biosimilar competition. The US biosimilars market is expected to reach nearly $23,000 million by the end of 2027, being worth $737.2

Production 98

Production Drugs Marketing Sales 98

XTalks

OCTOBER 22, 2020

The information shared between different multidisciplinary teams is critical to reducing the cost and ultimately accelerating the path of bringing a drug to market. To achieve transparency and actionability of data, pharmaceutical companies are evolving their manufacturing processes by digitalizing the data from all of their equipment.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

OCTOBER 5, 2020

The 68-year-old – credited with being a catalyst for Merck’s highly lucrative move into cancer immunotherapy – will officially retire from the big pharma company at the end of the year. He will be succeeded by Dean Li, who is currently Merck’s senior vice president of discovery sciences and translational medicine.

Sales 52

Sales Medicine FDA Approval Vaccination 52